Open AccessCurrent state of the problem and results of <i>ex vivo</i> perfusion of donor hearts
Author(s) -
M.O. Zhulkov,
А. В. Фомичев,
С. А. Альсов,
Elena Kliver,
А. М. Чернявский
Publication year - 2020
Publication title -
vestnik transplantologii i iskusstvennyh organov
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.137
H-Index - 5
eISSN - 2412-6160
pISSN - 1995-1191
DOI - 10.15825/1995-1191-2019-4-143-146
Subject(s) - economic shortage , medicine , intensive care medicine , transplantation , refractory (planetary science) , perfusion , ex vivo , cardiology , heart transplantation , heart failure , heart transplants , surgery , in vivo , linguistics , philosophy , physics , microbiology and biotechnology , government (linguistics) , astrobiology , biology
Patients with drug refractory end-stage heart failure fall into the severe category of cardiological patients. Numerous studies have shown the superior efficacy of heart transplantation over other treatments for end-stage chronic heart failure. However, despite decades of achievements in transplantology, shortage of donor organs remains a pressing and unresolved issue. The only way to reduce shortage of donor organs is to use donors with advanced criteria, which requires the use of latest technologies in organ resuscitation and conditioning.